Market Research Reports, Inc. has announced the addition of “Global Left Atrial Appendage Closure Market 2017 - 2021” research report to their website www.MarketResearchReports.com

Lewes, DE -- (SBWire) -- 02/13/2017 --Report forecast the global left atrial appendage closure market to grow at a CAGR of 33.54% during the period 2017-2021.

Atrial fibrillation is one of the most common types of arrhythmia and is characterized by fast and irregular heart rhythms. The atria of patients suffering from the disease do not function properly. Atrial fibrillation can cause chest pain, heart failure, or stroke. The doctor needs to identify the first detected event of atrial fibrillation in a patient. The occurrence of two or more events of atrial fibrillation results in it being considered recurrent. In paroxysmal atrial fibrillation, the arrhythmia ends spontaneously, whereas in persistent atrial fibrillation the arrhythmia continues for more than a week.

The report covers the present scenario and the growth prospects of the global left atrial appendage closure market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sale of medical devices required for left atrial appendage closure.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

According to the report, the growing incidences of atrial fibrillation increase the demand for LAA closure devices. Atrial fibrillation is the most common type of heart arrhythmia in which the heart beats at a rapid and irregular pace. The irregular heart rhythm fluctuates the blood flow from the heart, causing blood to stagnate in the LAA, form clots, and increase the risk of stroke. There are some risk factors such as diabetes, cigarette smoking, obesity, and cardiovascular diseases that lead to atrial fibrillation. LAA closure devices play a pivotal role in managing stroke risk in atrial fibrillation patients. Among the many cardiovascular diseases, atrial fibrillation is a common risk factor, which leads to stroke in some individuals. The LAA closure device is used to close the appendage that occurs in the left atria and reduces the risk of stroke. LAA closure devices are minimally invasive, which offers a novel approach for atrial fibrillation treatment.

Further, the report states that rrugs are an alternative treatment option for LAA closure devices. Though these devices are more effective and safer than drugs, they are less preferred. LAA closure device costs are required only once, while costs for warfarin and dabigatran continue to accrue year over year. This factor compels the preference for warfarin and dabigatran by consumers. The drugs used to treat diseases are less invasive in nature. Also, warfarin and dabigatran are used for treatment instead of LAA closure devices, as only a few people are aware of LAA closure devices, and its implants have complicated procedures. Also, the introduction of improved drug delivery techniques and enhanced drug pipelines for the treatment of atrial fibrillation diseases restrict the market growth. Thus, the increased acceptance of warfarin and dabigatran will hamper the growth of the market.

Global Left Atrial Appendage Closure Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global left atrial appendage closure market: AtriCure, Boston Scientific, Coherex Medical, and St. Jude Medical

Other Prominent Vendors in the market are: Occlutech, Lifetech Scientific, and SentreHEART

Market driver
- Increasing incidences of atrial fibrillation
- For a full, detailed list, view our report

Market challenge
- Increasing product recalls hindering growth prospects
- For a full, detailed list, view our report

Market trend
- Emergence of 3D printing technology
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 115 pages and 70 Exhibits "Global Left Atrial Appendage Closure Market 2017 - 2021" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Pipeline analysis, Clinical trials, Regulation of LAA closure devices, Market segmentation by product type, Market segmentation by end-user, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.marketresearchreports.com/technavio/global-left-atrial-appendage-closure-market-2017-2021

Related Reports;

Global Chemotherapy-induced Nausea and Vomiting Drugs Market 2017-2021 - Visit at - http://www.marketresearchreports.com/technavio/global-chemotherapy-induced-nausea-and-vomiting-drugs-market-2017-2021

Global Infantile Spasms Therapeutics Market 2017-2021 - Visit at - http://www.marketresearchreports.com/technavio/global-infantile-spasms-therapeutics-market-2017-2021

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions